These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26050711)

  • 1. Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Takada T; Nochioka K; Miura M; Tadaki S; Ushigome R; Sato K; Onose T; Tsuji K; Abe R; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2015; 79(9):1984-93. PubMed ID: 26050711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of New-Onset Atrial Fibrillation in Patients With Chronic Heart Failure - A Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Miura M; Tadaki S; Ushigome R; Sato K; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Nochioka K; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2016; 80(1):157-67. PubMed ID: 26639067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia Is Associated With Blunted Response to β-Blocker Therapy Using Carvedilol　- Insights From Japanese Chronic Heart Failure (J-CHF) Study.
    Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M;
    Circ J; 2018 Feb; 82(3):691-698. PubMed ID: 28883225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure.
    Petretta M; Scopacasa F; Fontanella L; Carlomagno A; Baldissara M; de Simone A; Petretta MP; Bonaduce D
    J Cardiovasc Med (Hagerstown); 2007 Nov; 8(11):909-16. PubMed ID: 17906476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
    Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
    Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan -- report from the CHART Studies.
    Ushigome R; Sakata Y; Nochioka K; Miyata S; Miura M; Tadaki S; Yamauchi T; Sato K; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Takahashi J; Shimokawa H;
    Circ J; 2015; 79(11):2396-407. PubMed ID: 26356834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
    von Haehling S; van Veldhuisen DJ; Roughton M; Babalis D; de Boer RA; Coats AJ; Manzano L; Flather M; Anker SD
    Eur J Heart Fail; 2011 Jun; 13(6):656-63. PubMed ID: 21613429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
    J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure.
    Takagi A; Iwama Y; Yamada A; Aihara K; Daida H
    J Cardiol; 2010 May; 55(3):317-21. PubMed ID: 20350524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical manifestations of anemia syndrome and its significance in the course of chronic heart failure in elderly patients].
    Larina VN; Bart BIa
    Ter Arkh; 2014; 86(3):53-8. PubMed ID: 24779071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.